139 | ENHANCED CAR T‐CELL EXPANSION AND DURABLE COMPLETE RESPONSES WITH NKTR‐255 PLUS LISOCABTAGENE MARALEUCEL IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMAAlexandre V. Hirayama, Cameron J. Turtle, Barbara Pender et al.|Hematological Oncology|2025Cited by 1
1026TiP A phase Ib/II, open-label, multicenter, dose-escalation and dose-expansion study of NKTR-255 plus cetuximab as a salvage regimen in patients with solid tumorsMehmet Altan, Assuntina G. Sacco, Amita Patnaik et al.|Annals of Oncology|2021Cited by 0